DocGo

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DocGo reports stellar 2022 performance and outlines growth strategies

DocGo's strong financial performance in 2022, coupled with robust guidance for 2023 and strategic operational initiatives, positions the company for continued growth and profitability.
While challenges like managing PHE impacts and transitioning to leased hour contracts exist, DocGo's proactive approach and operational strengths provide a solid foundation for addressing these hurdles.
With a focus on optimizing operations, pursuing growth opportunities, and leveraging its financial resources effectively, DocGo is poised to capitalize on market opportunities and deliver value to stakeholders.

DocGo reports Q1 revenue growth amidst margin challenges and future opportunities

DocGo's Q1 2023 performance showcased revenue growth and margin challenges, with a focus on improving margins through normalization initiatives.
Strengths include strong revenue guidance, significant contract opportunities, and partnerships driving backlog growth and revenue diversification.
Challenges stem from replacing high-margin COVID revenue, startup costs impacting margins, and negative cash flow in Q1 2023.
Opportunities lie in future revenue growth from new contracts, RPM services, public-private partnerships, and potential contract wins from upcoming RFPs.

DocGo (DCGO) reports stellar Q2 results, raises full-year guidance

DocGo's Q2 2023 showcased exceptional financial performance, with revenue and EBITDA growth exceeding expectations, underpinned by strong operational metrics and strategic decisions.
While facing challenges in backlog conversion and margin improvements, the company's focus on scalability, employee satisfaction, and market expansion positions it well for future growth.
Opportunities in new geographies, Remote Patient Monitoring integration, and transportation segment enhancements provide avenues for sustained revenue growth and operational excellence.

DocGo reports record Q3 revenue, eyes growth in commercial sector

DocGo's Q3 performance reflects strong revenue growth and improved EBITDA margins, driven by the success of Mobile Health and Transportation Services. While facing challenges with working capital and payment delays, the company is focused on catching up by year-end.
The company's strengths in contract performance, revenue guidance increase, and backlog diversification position it well for future growth. DocGo's strategic focus on commercial business expansion and customer experience enhancement aligns with its growth objectives.

DocGo reports record Q4 earnings, eyes growth in healthcare

DocGo delivered exceptional financial results in Q4 2023, showcasing robust revenue growth and profitability, driven by operational excellence and strategic investments.
While facing margin and cost challenges, the company's focus on growth, value-based care agreements, and revenue diversification positions it well for future success and market expansion.
With a strong cash position, revised revenue guidance, and proactive pursuit of new partnerships, DocGo is poised to capitalize on growth opportunities and navigate challenges effectively.
The company's commitment to transforming healthcare delivery and gratitude towards its staff underscore a resilient corporate culture and a dedication to driving positive impact in the industry.

DocGo reports robust Q1 earnings, eyes growth through unique care model

DocGo's Q1 2024 performance was strong, marked by revenue growth, improved margins, and profitability.
While facing challenges like revenue fluctuations and working capital pressures, the company is well-positioned for growth.
Opportunities lie in becoming a primary care provider, monetization strategies, and market differentiation through quality care.
Overall, DocGo's financial stability, growth plans, and unique service offerings position them for future success in the healthcare sector.

DocGo excels in Q2 2024, sets sights on clinical innovation

DocGo's Q2 2024 performance reflects financial strength and strategic advancements in clinical expertise and service expansion.
While facing challenges in meeting ambitious care gap closure targets, the company is well-positioned for growth.
Leveraging opportunities in mobile healthcare services and clinical program development can drive future success for DocGo.

DocGo reports robust Q3 earnings, eyes growth in migrant-related work

DocGo's Q3 2024 earnings call showcased strong financial performance, operational efficiency, and positive outlook for future revenue and cash flow.
While challenges such as revenue balancing and margin expectations were noted, opportunities for growth through migrant-related work and care programs were highlighted.
Overall, DocGo's performance and strategic direction position the company well for continued success and expansion in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Shares of DocGo (NASDAQ: DCGO ), a company known for its mobile medical services, are plunging lower following the publication of a short report by Fuzzy Panda. The short seller has accused the company of improper billing practices, a management team with connections to fraud and unethical practices and contract issues in regards to New York City migrant asylum seekers, among other allegations.

Fuzzy Panda Slams DocGo (DCGO) Stock in New Short Report

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of DocGo Inc. (NASDAQ: DCGO) resulting from allegations that DocGo may have issued materially misleading business information to the investing public. SO WHAT: If you purchased DocGo securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen La.

DCGO LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages DocGo Inc. Investors to Inquire About Securities Class Action Investigation – DCGO

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that its medical staffing division that services federal agencies achieved the coveted ISO 9001:2015 certification. This Quality Management Systems (“QMS”) standard sets the bar for quality assurance, emphasizing continuous improvement, customer satisfaction, and efficient processes. This certification represents a significant milestone, demonstrating.

DocGo Subsidiary Achieves ISO 9001:2015 Certification, Further Elevating its Commitment to Quality Management

DocGo Chief Executive Lee Bienstock is standing by the mobile-healthcare company's performance under a controversial migrant-care contract awarded by New York City.

DocGo CEO Defends Performance on New York City Migrant-Care Contract

LOS ANGELES , Dec. 26, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against DocGo Inc. ("DocGo" or the "Company") (NASDAQ: DCGO). Class Period: November 8, 2022 – September 17, 2023 Lead Plaintiff Deadline: December 26, 2023 If you wish to serve as lead plaintiff of the DocGo lawsuit, you can submit your contact information at www.glancylaw.com/cases/DocGo-Inc/.

DCGO Investors Have Opportunity to Lead DocGo Inc. Securities Fraud Lawsuit

NEW YORK , Dec. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DocGo Inc. ("DocGo" or the "Company") (NASDAQ: DCGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DocGo investors who were adversely affected by alleged securities fraud between November 8, 2022 and September 17, 2023.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies DocGo Inc.(DCGO) Investors of a Class Action Lawsuit and Upcoming Deadline

LOS ANGELES, CA / ACCESSWIRE / December 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

NEW YORK , Dec. 23, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

DCGO TUESDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages DocGo Inc. Investors to Secure Counsel Before Important December 26 Deadline in Securities Class Action - DCGO

NEW YORK , Dec. 21, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DocGo Inc. ("DocGo" or "the Company") (NASDAQ: DCGO) and certain of its officers.  Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DocGo securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period").

DCGO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DocGo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 26, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired DocGo Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) securities between November 8, 2022 and September 17, 2023, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On July 30, 2023, the New York Times reported that DocGo's migr.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DocGo Inc. (DCGO)

If you suffered losses exceeding $100,000 investing in DocGo securities between November 8, 2022 and September 17, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DCGO.

DOCGO INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In DocGo To Contact Him Directly To Discuss Their Options

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services today announced their partnership to provide event medical services at Enchant Milwaukee's Winter Village. DocGo's innovative approach to mobile healthcare aligns closely with Enchant Milwaukee's Winter Village's commitment to ensuring the safety and well-being of its event attendees. DocGo's expert clinical staff will help support the overall visitor experience by offering medi.

DocGo Delivers Medical Services at Enchant Milwaukee's Winter Village

LOS ANGELES, CA / ACCESSWIRE / December 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE DAYS AWAY: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

NEW YORK--(BUSINESS WIRE)--DocGo expands mobile health services with Santa Cruz County, Arizona Department of Health. New clinic expands vaccination access in the county.

DocGo Expands Mobile Health Services with Santa Cruz County, Arizona Department of Health

LOS ANGELES, CA / ACCESSWIRE / December 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

NEW YORK , Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DocGo Inc. ("DocGo" or the "Company") (NASDAQ: DCGO) and certain officers.   The class action, filed in the United States District Court for the Southern District of New York, and docketed under 23-cv-09476, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired DocGo securities between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act").

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DocGo Inc. of Class Action Lawsuit and Upcoming Deadline - DCGO

NEW YORK , Dec. 18, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DocGo Inc.. Shareholders who purchased shares of DCGO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023 - (NASDAQ: DCGO)

NEW YORK , Dec. 16, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

DCGO DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages DocGo Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

LOS ANGELES, CA / ACCESSWIRE / December 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE THIS MONTH: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

NEW YORK , Dec. 11, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DocGo Inc. (NASDAQ: DCGO) between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), of the important December 26, 2023 lead plaintiff deadline. SO WHAT: If you purchased DocGo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

TOP RANKED ROSEN LAW FIRM Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DCGO

LOS ANGELES, CA / ACCESSWIRE / December 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 8, 2022 and September 17, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before December 26, 2023.

FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DocGo Inc. with Losses to Contact the Firm

DOCGO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In DocGo To Contact Him Directly To Discuss Their Options

News for DocGo Stock (DCGO)